Home > Balance Sheet > VALIANT LABORATORIES

VALIANT LABORATORIES
Balance Sheet

VALIANT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Balance Sheet History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
EQUITY AND LIABILITIES
Share Capital ₹54 Cr₹43 Cr₹43 Cr₹33 Cr
    Equity - Authorised ₹60 Cr₹60 Cr₹45 Cr₹45 Cr
    Equity - Issued ₹54 Cr₹43 Cr₹43 Cr₹33 Cr
    Equity Paid Up ₹54 Cr₹43 Cr₹43 Cr₹33 Cr
    Equity Shares Forfeited ----
    Adjustments to Equity ----
    Preference Capital Paid Up ----
    Face Value ₹10.00₹10.00₹10.00₹10.00
Share Warrants & Outstandings ----
Total Reserves ₹257 Cr₹191 Cr₹193 Cr₹68 Cr
    Securities Premium ₹210 Cr₹141 Cr₹141 Cr₹16 Cr
    Capital Reserves ----
    Profit & Loss Account Balance ₹47 Cr₹50 Cr₹52 Cr₹52 Cr
    General Reserves ----
    Other Reserves ₹-0.01 Cr₹-0.02 Cr--
Reserve excluding Revaluation Reserve ₹257 Cr₹191 Cr₹193 Cr₹68 Cr
Revaluation reserve ----
Shareholder's Funds ₹311 Cr₹234 Cr₹237 Cr₹100 Cr
Minority Interest ----
Long-Term Borrowings ----
Secured Loans ₹28 Cr₹45 Cr₹15 Cr-
    Non Convertible Debentures ----
    Converible Debentures & Bonds ----
    Packing Credit - Bank ----
    Inter Corporate & Security Deposit ----
    Term Loans - Banks ₹28 Cr₹45 Cr₹15 Cr-
    Term Loans - Institutions ----
    Other Secured ----
Unsecured Loans -₹59 Cr₹59 Cr₹59 Cr
    Fixed Deposits - Public ----
    Loans and advances from subsidiaries ----
    Inter Corporate Deposits (Unsecured) ----
    Foreign Currency Convertible Notes ----
    Long Term Loan in Foreign Currency ----
    Loans - Banks ----
    Loans - Govt. ----
    Loans - Others -₹59 Cr₹59 Cr₹59 Cr
    Other Unsecured Loan ----
Deferred Tax Assets / Liabilities ₹3.65 Cr₹1.24 Cr₹0.62 Cr₹0.67 Cr
    Deferred Tax Assets ₹0.44 Cr₹0.63 Cr₹0.68 Cr₹0.52 Cr
    Deferred Tax Liability ₹4.09 Cr₹1.87 Cr₹1.30 Cr₹1.19 Cr
Other Long Term Liabilities ₹1.76 Cr₹1.21 Cr₹1.39 Cr₹1.60 Cr
Long Term Trade Payables ----
Long Term Provisions ₹0.15 Cr₹0.13 Cr₹0.08 Cr₹0.08 Cr
Total Non-Current Liabilities ₹34 Cr₹107 Cr₹77 Cr₹62 Cr
Current Liabilities ----
Trade Payables ₹94 Cr₹41 Cr₹26 Cr₹47 Cr
    Sundry Creditors ₹94 Cr₹41 Cr₹26 Cr₹47 Cr
    Acceptances ----
    Due to Subsidiaries- Trade Payables ----
Other Current Liabilities ₹8.25 Cr₹1.84 Cr₹1.65 Cr₹3.31 Cr
    Bank Overdraft / Short term credit ----
    Advances received from customers ₹0.38 Cr₹0.00 Cr₹0.08 Cr₹0.84 Cr
    Interest Accrued But Not Due ----
    Share Application Money ----
    Current maturity of Debentures & Bonds ----
    Current maturity - Others ----
    Other Liabilities ₹7.86 Cr₹1.84 Cr₹1.57 Cr₹2.47 Cr
Short Term Borrowings ₹17 Cr₹17 Cr₹1.39 Cr-
    Secured ST Loans repayable on Demands ₹17 Cr₹17 Cr₹1.39 Cr-
    Working Capital Loans- Sec ₹17 Cr₹17 Cr₹1.39 Cr-
    Buyers Credits - Unsec ----
    Commercial Borrowings- Unsec ----
    Other Unsecured Loans ₹-17 Cr₹-17 Cr₹-1.39 Cr-
Short Term Provisions ₹0.32 Cr₹0.20 Cr₹0.12 Cr₹0.12 Cr
    Proposed Equity Dividend ----
    Provision for Corporate Dividend Tax ----
    Provision for Tax ----
    Provision for post retirement benefits ----
    Preference Dividend ----
    Other Provisions ₹0.32 Cr₹0.20 Cr₹0.12 Cr₹0.12 Cr
Total Current Liabilities ₹119 Cr₹60 Cr₹29 Cr₹51 Cr
Total Liabilities ₹464 Cr₹401 Cr₹343 Cr₹213 Cr
ASSETS
Gross Block ₹255 Cr₹71 Cr₹70 Cr₹66 Cr
Less: Accumulated Depreciation ₹28 Cr₹22 Cr₹20 Cr₹18 Cr
Less: Impairment of Assets ----
Net Block ₹227 Cr₹48 Cr₹50 Cr₹48 Cr
Lease Adjustment A/c ----
Capital Work in Progress ₹6.09 Cr₹156 Cr₹43 Cr₹0.68 Cr
Non Current Investments ----
Long Term Investment ----
    Quoted ----
    Unquoted ----
Long Term Loans & Advances ₹2.41 Cr₹4.02 Cr₹24 Cr₹14 Cr
Other Non Current Assets ₹0.03 Cr---
Total Non-Current Assets ₹236 Cr₹208 Cr₹117 Cr₹62 Cr
Current Assets Loans & Advances ----
Currents Investments ₹26 Cr-₹38 Cr₹34 Cr
    Quoted ₹26 Cr-₹38 Cr₹34 Cr
    Unquoted ----
Inventories ₹45 Cr₹3.99 Cr₹10 Cr₹13 Cr
    Raw Materials ₹39 Cr₹1.45 Cr₹3.66 Cr₹7.87 Cr
    Work-in Progress ₹2.40 Cr₹0.57 Cr₹3.03 Cr₹2.06 Cr
    Finished Goods ₹2.65 Cr₹1.79 Cr₹3.20 Cr₹3.03 Cr
    Packing Materials ₹0.09 Cr₹0.06 Cr₹0.07 Cr₹0.02 Cr
    Stores  and Spare ₹0.95 Cr₹0.12 Cr₹0.06 Cr₹0.06 Cr
    Other Inventory ----
Sundry Debtors ₹94 Cr₹72 Cr₹46 Cr₹89 Cr
    Debtors more than Six months ₹2.32 Cr₹2.36 Cr₹0.71 Cr₹0.22 Cr
    Debtors Others ₹92 Cr₹71 Cr₹45 Cr₹89 Cr
Cash and Bank ₹7.06 Cr₹76 Cr₹106 Cr₹1.34 Cr
    Cash in hand ₹0.03 Cr₹0.09 Cr₹0.06 Cr₹1.19 Cr
    Balances at Bank ₹7.02 Cr₹76 Cr₹106 Cr₹0.15 Cr
    Other cash and bank balances ----
Other Current Assets ₹5.31 Cr₹0.81 Cr₹2.02 Cr₹1.24 Cr
    Interest accrued on Investments -₹0.40 Cr--
    Interest accrued on Debentures ----
    Deposits with Government ----
    Interest accrued and or due on loans ----
    Prepaid Expenses ₹0.16 Cr₹0.15 Cr₹0.14 Cr₹0.52 Cr
    Other current_assets ₹5.16 Cr₹0.25 Cr₹1.87 Cr₹0.72 Cr
Short Term Loans and Advances ₹51 Cr₹40 Cr₹24 Cr₹12 Cr
    Advances recoverable in cash or in kind ₹2.69 Cr₹0.39 Cr₹0.16 Cr₹4.02 Cr
    Advance income tax and TDS ₹1.68 Cr₹2.19 Cr₹4.08 Cr₹1.90 Cr
    Amounts due from directors ----
    Due From Subsidiaries ----
    Inter corporate deposits ----
    Corporate Deposits ----
    Other Loans & Advances ₹46 Cr₹37 Cr₹20 Cr₹6.45 Cr
Total Current Assets ₹228 Cr₹193 Cr₹226 Cr₹151 Cr
Net Current Assets (Including Current Investments) ₹109 Cr₹133 Cr₹196 Cr₹100 Cr
Miscellaneous Expenses not written off ----
Total Assets ₹464 Cr₹401 Cr₹343 Cr₹213 Cr
Contingent Liabilities ₹49 Cr₹62 Cr₹0.03 Cr₹0.03 Cr
Total Debt ₹45 Cr₹121 Cr₹76 Cr₹59 Cr
Book Value 57.2453.9354.5130.86
Adjusted Book Value 57.2450.0550.6028.65

Compare Balance Sheet of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹694.5 Cr -0.8% 7.2% 46.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 1.1% -4.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.5% 1.3% 45.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.8% -6.3% 26.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 9.3% 9.5% 4.3% Stock Analytics
CIPLA ₹111,489.0 Cr 1.5% -2.3% -17.3% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-0.8%

7.2%

46.1%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses